Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
Düsseldorf University Hospital · Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · +105 more institutions
Abstract
Candida species are the predominant cause of fungal infections in patients treated in hospital, contributing substantially to morbidity and mortality. Candidaemia and other forms of invasive candidiasis primarily affect patients who are immunocompromised or critically ill. In contrast, mucocutaneous forms of candidiasis, such as oral thrush and vulvovaginal candidiasis, can occur in otherwise healthy individuals. Although mucocutaneous candidiasis is generally not life-threatening, it can cause considerable discomfort, recurrent infections, and complications, particularly in patients with underlying conditions such as diabetes or in those taking immunosuppressive therapies. The rise of difficult-to-treat…
Citation impact
- FWCI
- 290.94
- Percentile
- 100%
- References
- 36
Authors
105- OAOliver A. CornelyCorresponding
Düsseldorf University Hospital, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, University Hospital Cologne, Heinrich Heine University Düsseldorf
- RSRosanne Sprute
Düsseldorf University Hospital, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, University Hospital Cologne, Heinrich Heine University Düsseldorf
- MBMatteo Bassetti
Ospedale Policlinico San Martino
- WCWen Chen
New South Wales Department of Health, Westmead Hospital
- AHAndreas H. Groll
University Hospital Münster
Topics & keywords
- Intensive care medicine
- Fluconazole
- Candida auris
- Mucocutaneous zone
- Guideline
- Medicine
- Invasive candidiasis
- Antifungal
Funding
- NSNational Science FoundationAward: BB/W002760/1
- JMJeffrey Modell Foundation
- PPfizer
- AAstraZeneca
- SSanofi
- GSGilead Sciences
- IDInfectious Diseases Society of America
- DODivision of Intramural Research, National Institute of Allergy and Infectious Diseases
- ACAmerican College of Veterinary Internal Medicine
- CBCSL Behring
- MUMcGill University
- DZDeutsches Zentrum für Infektionsforschung
- SSunovion
- HKHELIOS Kliniken
- CTCidara Therapeutics
- PHPublic Health Agency of Canada
- JPJazz Pharmaceuticals
- JPJoint Programming Initiative on Antimicrobial Resistance
- MUMcGill University Health Centre
- MMylan
- MModerna
- GPGlenmark Pharmaceuticals
- AOAssociation of Medical Microbiology and Infectious Disease Canada
- NINational Institute for Health and Care ResearchAward: NIHR203308
- DCDowager Countess Eleanor Peel Trust
- PHPublic Health Agency
- DFDeutsche Forschungsgemeinschaft
- UVUniversiteit van Amsterdam
- BFBundesministerium für Bildung und Forschung
- UOUniversity of Toronto
- TATel Aviv University
- APAstellas Pharma
- SShionogi
- LMLudwig-Maximilians-Universität München
- UOUniversity of Cape Town
- UZUniversität zu Köln
- KGKarl-Franzens-Universität Graz
- MUMedizinische Universität Graz
- NHNational Health Laboratory Service
- IDInstituto de Investigación Sanitaria Gregorio Marañón
- MCMerck Canada
- FDFondation de l'Hôpital Général de Montréal
- NINational Institutes of Health
- DFDirectorate for Biological Sciences
- PJPfizer Japan
- PCPfizer Canada
- SPSanofi Pasteur
- MBManchester Biomedical Research CentreAward: NIHR203308
- CICanadian Institutes of Health Research
- IDInstituto de Salud Carlos III
- NINational Institute of Allergy and Infectious Diseases
- JPJanssen Pharmaceuticals
- NDNHLBI Division of Intramural Research